Skip to content
2000
Volume 21, Issue 1
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

MicroRNAs regulate gene expression at the posttranscriptional level by binding to the mRNA of their target genes. The dysfunction of miRNAs is strongly associated with the inflammation of the colon. Besides, some microRNAs are shown to suppress tumours, while others promote tumour progression and metastasis. Inflammatory bowel diseases include Crohn’s disease and Ulcerative colitis, which increase the risk factor for inflammation-associated colon cancer. MicroRNAs are shown to be involved in gastrointestinal pathologies by targeting the transcripts encoding proteins of the intestinal barrier and their regulators that are associated with inflammation and colon cancer. Detection of these microRNAs in the blood, serum, tissues, faecal matter, etc, will enable us to use these microRNAs as biomarkers for early detection of the associated malignancies and design novel therapeutic strategies to overcome the same. Information on MicroRNAs can be applied for the development of targeted therapies against inflammation-mediated colon cancer.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/1871530320666200825184924
2021-01-01
2025-05-25
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/1871530320666200825184924
Loading

  • Article Type:
    Review Article
Keyword(s): biomarkers; colon cancer; Crohn's disease; metastasis; MicroRNA; ulcerative colitis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test